  See all
 |
Articles: Pharmacology/Therapy |
Prior Articles
Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer
Cancer, 10/26/09
Exclusive Author Commentary
Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia
Cancer, 10/26/09 A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia
Clinical Cancer Research, 10/26/09 T Cell–Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective
Clinical Cancer Research, 10/26/09 Radiation therapy for intrahepatic malignancies
Expert Review of Anticancer Therapy, 10/26/09 State-of-the-art lung cancer radiation therapy
Expert Review of Anticancer Therapy, 10/26/09 Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies
British Journal of Cancer, 10/26/09 HuR modulates gemcitabine efficacy: new perspectives in pancreatic cancer treatment
Expert Review of Anticancer Therapy, 10/26/09 Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications
Expert Review of Anticancer Therapy, 10/26/09
Revew Article
Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
British Journal of Cancer, 10/26/09 Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
Cancer Science, 10/26/09 Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma
Journal of Neuro-Oncology, 10/26/09 Predicting for activity of second-line trastuzumab-based therapy in Her2-positive advanced breast cancer
BMC Cancer, 10/23/09
Free full text
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09 Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors
European Journal of Cancer, 10/23/09 The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer
European Journal of Cancer, 10/23/09 Phase I trial of vinflunine and pemetrexed in refractory solid tumors
Investigational New Drugs, 10/23/09 Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer
Cancer Investigation, 10/23/09 Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma
Investigational New Drugs, 10/23/09 Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
International Journal of Hematology, 10/23/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
